HomeACQUISITIONS and MERGERS
ACQUISITIONS and MERGERS
Medical Device News Magazine is the leading resource for medical device M&A information. We provide coverage of all the latest deals, as well as insights and analyses from industry experts.
Our readers rely on us for the most up-to-date information on the medical device market. We are focused on delivering the most comprehensive news coverage possible. Whether you are a CEO, CFO, investor, or employee of a medical device company, MDNM is the source you can trust for all your merger and acquisition news.
Philips Signs An Agreement to Acquire Capsule Technologies, Inc
“Integrated patient care management solutions supported by essential real-time patient data and AI are core to our strategy to improve patient outcomes and care provider productivity by seamlessly connecting care,” said Roy Jakobs, Chief Business Leader Connected Care at Royal Philips.
Thermo Fisher Scientific Completes Acquisition of Viral Vector Manufacturing Business from Novasep for Approximately €725 Mil in Cash
The company notes that Novasep's viral vector manufacturing business provides contract manufacturing services for vaccines and therapies to biotechnology companies and large biopharma customers.
Mavens Is Acquired by Komodo Health
“This acquisition disrupts the status quo, unlocking a fundamentally different opportunity for life sciences companies to gain access to differentiated insights through technology,” said Arif Nathoo, MD, CEO and co-founder of Komodo Health.
Celularity and GX Acquisition Corp. Announce Merger Agreement to Create a Publicly Listed Leader in Allogeneic Cellular Therapy
January 8,2021
Celularity Inc. is a clinical-stage biotechnology company, and leading the next evolution in cellular medicine with the development of off-the-shelf allogeneic therapies derived...
Merck Acquires AmpTec – Adds to Merck’s Lipid Manufacturing Expertise, Providing an Integrated Offering Across mRNA Value Chain
"The success of mRNA-based vaccines for Covid-19 lays the path to accelerate the development of these therapeutics for many other diseases," said Stefan Oschmann, Chairman of the Executive Board and CEO of Merck.
Bioclinica Acquires Saliency to Accelerate Digital Diagnostic Development
Bioclinica will integrate the company’s advanced AI technology into its Imaging Platform to support a growing portfolio of pharmaceutical and medical device clients.
NAMSA ® Acquires Syntactx to Enhance End-to-End CRO Development Solutions, Expanding Medical Device Clinical Research Capabilities and Expertise
“Syntactx is very proud to join NAMSA, a long-recognized industry leader in CRO medical device development and clinical research services,” stated Dr. Kenneth Ouriel, President and CEO of Syntactx.
Exact Sciences Completes Acquisition of Thrive Earlier Detection: Blood-Based Multi-Cancer Screening Becomes a Reality & Eventually the Standard of Care Notes CEO
Chairman and CEO Kevin Conroy said, "Bringing Thrive into the Exact Sciences family marks a giant leap toward blood-based, multi-cancer screening becoming a reality and eventually the standard of care.
Collagen Matrix Acquires Sunstar’s Degradable Solutions Division
Founded in 1999, Degradable Solutions AG, is headquartered in Schlieren, Switzerland, and has been part of the Sunstar Group since 2011.
